4//SEC Filing
MacLeod Roderick H. 4
Accession 0001610717-24-000138
CIK 0001444380other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:25 PM ET
Size
6.3 KB
Accession
0001610717-24-000138
Insider Transaction Report
Form 4
NEVRO CORPNVRO
MacLeod Roderick H.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-03-04$14.51/sh−438$6,355→ 63,514 total - Award
Common Stock
2024-03-04+743→ 63,952 total
Footnotes (2)
- [F1]Represents Performance Stock Units ("PSUs") initially granted on February 28, 2022 that were subject to a performance-based vesting condition. The Compensation Committee of the Issuer certified the achievement of the first milestone vesting condition upon which a portion of the PSUs vested.
- [F2]Includes 50,531 restricted stock units.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001815111
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:25 PM ET
- Size
- 6.3 KB